Uniphar PLC on Tuesday reported interim revenue growth, citing a ‘strong performance’ in its divisions as it expects gross profit growth for the full year.

For the six months that ended June 30, the Dublin-headquartered healthcare services business company said pretax profit edged down by 1.9% to €20.3 million from €20.7 million a year earlier, as exceptional costs rose to €5.8 million from €3.1 million.

Revenue, however, rose 2.8% to €991.8 million from €964.9 million, driven by a ‘strong performance in the Supply Chain & Retail and Commercial & Clinical divisions together with the impact of the 2021 acquisitions,’ it said.

Supply Chain & Retail division revenue increased by 4.7% to €755.0 million from €721.1 million, while Commercial & Clinical division revenue rose 2.9% to €162.3 million from €157.8 million.

Earnings before interest, tax, depreciation and amortisation rose 9.2% to €44.9 million from €41.1 million a year earlier.

‘Uniphar delivered a strong performance during the first six months of 2022 leveraging its scalable platforms to help mitigate the impact of inflationary pressures and global economic uncertainty,’ it said.

Uniphar declared an interim dividend of €0.0061 per share, up 8.9% at €0.0056.

Looking ahead, Uniphar said cost inflation remains a concern and will be a key focus through this year and the next. But it said it is well positioned to drive gross profit growth across all divisions and is confident of delivering on current trading expectations for the full year.

Shares were down 3.9% at 286.00 pence each on Tuesday morning in London.

Copyright 2022 Alliance News Limited. All Rights Reserved.